002007 华兰生物
已收盘 04-02 15:00:00
资讯
新帖
简况
华兰生物：截至2026年3月31日，公司共有14.8万多名投资者
证券之星 · 04-01 15:15
华兰生物：截至2026年3月31日，公司共有14.8万多名投资者
华兰生物（002007）披露2025年年度报告，3月30日股价上涨0.96%
证券之星 · 03-30
华兰生物（002007）披露2025年年度报告，3月30日股价上涨0.96%
华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.47%
证券之星 · 03-28
华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.47%
华兰生物：第九届董事会第四次会议审议通过《2025年度总经理工作报告》等多项议案
证券日报网 · 03-27
华兰生物：第九届董事会第四次会议审议通过《2025年度总经理工作报告》等多项议案
华兰生物(002007.SZ)发布2025年度业绩，归母净利润9.4亿元，同比下降13.55%
智通财经 · 03-27
华兰生物(002007.SZ)发布2025年度业绩，归母净利润9.4亿元，同比下降13.55%
华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份
证券之星 · 03-18
华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份
股市必读：华兰生物(002007)股东户数14.9万户，较上期减少1.32%
证券之星 · 03-16
股市必读：华兰生物(002007)股东户数14.9万户，较上期减少1.32%
华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.32%
证券之星 · 03-13
华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.32%
股市必读：华兰生物（002007）3月6日董秘有最新回复
证券之星 · 03-09
股市必读：华兰生物（002007）3月6日董秘有最新回复
华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响
证券之星 · 03-06
华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响
华兰生物：血液制品中的罕见病药物仍适用3%简易征收
证券之星 · 03-06
华兰生物：血液制品中的罕见病药物仍适用3%简易征收
华兰生物(002007.SZ)：帕博利珠单抗注射液获准开展临床试验
智通财经 · 02-25
华兰生物(002007.SZ)：帕博利珠单抗注射液获准开展临床试验
华兰生物：截至2026年2月13日，公司共有15.1万多名投资者
证券之星 · 02-24
华兰生物：截至2026年2月13日，公司共有15.1万多名投资者
华兰生物：截至2026年2月10日，公司共有15.1万多名投资者
证券之星 · 02-11
华兰生物：截至2026年2月10日，公司共有15.1万多名投资者
华兰生物：截至2026年1月30日，公司共有15.3万多名投资者
证券之星 · 02-04
华兰生物：截至2026年1月30日，公司共有15.3万多名投资者
华兰生物：2025年已实现流感疫苗出口至巴基斯坦、多米尼加等国家
证券之星 · 02-04
华兰生物：2025年已实现流感疫苗出口至巴基斯坦、多米尼加等国家
华兰生物（002007）披露收到药物临床试验批准通知书，2月3日股价上涨1.05%
证券之星 · 02-03
华兰生物（002007）披露收到药物临床试验批准通知书，2月3日股价上涨1.05%
华兰生物(002007.SZ)：重组Exendin-4-Fc融合蛋白注射液获准开展临试
智通财经 · 02-03
华兰生物(002007.SZ)：重组Exendin-4-Fc融合蛋白注射液获准开展临试
股市必读：华兰生物（002007）1月23日董秘有最新回复
证券之星 · 01-26
股市必读：华兰生物（002007）1月23日董秘有最新回复
股市必读：华兰生物（002007）1月22日董秘有最新回复
证券之星 · 01-23
股市必读：华兰生物（002007）1月22日董秘有最新回复
加载更多
公司概况
公司名称：
华兰生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2004-06-25
主营业务：
华兰生物工程股份有限公司的主营业务是血液制品、疫苗、基因工程产品的研发、生产和销售。公司的主要产品是人血白蛋白、静注丙球、其他血液制品、流感疫苗。
发行价格：
15.74
{"stockData":{"symbol":"002007","market":"SZ","secType":"STK","nameCN":"华兰生物","latestPrice":14.86,"timestamp":1775113437000,"preClose":14.97,"halted":0,"volume":10843699,"delay":0,"changeRate":-0.0073,"floatShares":1573000000,"shares":1827000000,"eps":0.434,"marketStatus":"已收盘","change":-0.11,"latestTime":"04-02 15:00:00","open":14.9,"high":14.99,"low":14.8,"amount":161000000,"amplitude":0.0127,"askPrice":14.87,"askSize":54,"bidPrice":14.86,"bidSize":241,"shortable":0,"etf":0,"ttmEps":0.434,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775179800000},"marketStatusCode":5,"adr":0,"adjPreClose":14.97,"symbolType":"stock","openAndCloseTimeList":[[1775093400000,1775100600000],[1775106000000,1775113200000]],"highLimit":16.47,"lowLimit":13.47,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1827456666,"isCdr":false,"pbRate":2.38,"roa":"--","peRate":34.239631,"roe":"8.19%","epsLYR":0.5151,"committee":0.068944,"marketValue":27156000000,"turnoverRate":0.0069,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-04-08。","floatMarketCap":23378000000},"requestUrl":"/m/hq/s/002007","defaultTab":"news","newsList":[{"id":"2624971560","title":"华兰生物：截至2026年3月31日，公司共有14.8万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2624971560","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624971560?lang=zh_cn&edition=full","pubTime":"2026-04-01 15:15","pubTimestamp":1775027720,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年3月31日，公司股东人数多少？华兰生物回复：截至2026年3月31日，公司共有14.8万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100022175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002007","BK0197","BK0077","BK0185","BK0188","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623131393","title":"华兰生物（002007）披露2025年年度报告，3月30日股价上涨0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623131393","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623131393?lang=zh_cn&edition=full","pubTime":"2026-03-30 17:29","pubTimestamp":1774862979,"startTime":"0","endTime":"0","summary":"截至2026年3月30日收盘，华兰生物报收于14.68元，较前一交易日上涨0.96%，最新总市值为268.27亿元。近日，华兰生物工程股份有限公司披露《2025年年度报告》。公告显示，截至2025年末，公司总资产为15,262,266,713.76元，归属于上市公司股东的净资产为11,500,605,548.73元。2025年营业收入为4,595,017,702.01元，同比增长4.93%；归属于上市公司股东的净利润为940,400,665.87元，同比下降13.55%；扣除非经常性损益后的净利润为936,794,228.45元，同比下降4.51%。经营活动产生的现金流量净额为877,956,500.25元，同比下降17.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000024030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0188","BK0197","BK0046","BK0028","BK0185","002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622857133","title":"华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622857133","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622857133?lang=zh_cn&edition=full","pubTime":"2026-03-28 17:05","pubTimestamp":1774688738,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华兰生物披露，截至2026年3月10日公司股东户数为14.9万户，较2月28日减少2217.0户，减幅为1.47%。在生物制品行业个股中，华兰生物股东户数高于行业平均水平，截至3月10日，生物制品行业平均股东户数为3.48万户。从股价来看，2026年2月28日至2026年3月10日，华兰生物区间跌幅为0.71%，在此期间股东户数减少2217.0户，减幅为1.47%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032800021720.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0188","BK0028","BK0077","BK0046","BK0197","002007","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622873798","title":"华兰生物：第九届董事会第四次会议审议通过《2025年度总经理工作报告》等多项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2622873798","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622873798?lang=zh_cn&edition=full","pubTime":"2026-03-27 21:54","pubTimestamp":1774619640,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月27日，华兰生物发布公告称，公司第九届董事会第四次会议审议通过《2025年度总经理工作报告》等多项议案。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-27/doc-inhsmxrn5136959.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-27/doc-inhsmxrn5136959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0077","BK0188","BK0197","BK0046","BK0028","BK0185","002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622182899","title":"华兰生物(002007.SZ)发布2025年度业绩，归母净利润9.4亿元，同比下降13.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622182899","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622182899?lang=zh_cn&edition=full","pubTime":"2026-03-27 18:47","pubTimestamp":1774608453,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰生物(002007.SZ)发布2025年年度报告，报告期内，公司实现营业收入45.95亿元，同比增长4.93%。实现归属于上市公司股东的净利润9.4亿元，同比下降13.55%。实现归属于上市公司股东的扣除非经常性损益的净利润9.37亿元，同比下降4.51%。基本每股收益为0.5151元。拟向全体股东每10股派发现金红利5元(含税)。2025年公司实现采集血浆1669.49吨，较2024年增长5.24%，其中股份公司下属浆站实现采集血浆1015.02吨，较上年同期增长11.81%;重庆公司下属浆站实现采集血浆654.47吨，较上年同期下降3.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420616.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"华兰生物(002007.SZ)发布2025年度业绩，归母净利润9.4亿元，同比下降13.55%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620675239","title":"华兰生物：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2620675239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620675239?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:21","pubTimestamp":1773825667,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司持有华兰基因多少比例的股份？华兰生物回复：截至目前，公司持有华兰安康生物股份有限公司（原华兰基因）40%的股份，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800029977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0197","002007","BK0239","BK0196","BK0185","BK0188","BK0028","600201","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619100770","title":"股市必读：华兰生物(002007)股东户数14.9万户，较上期减少1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619100770","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619100770?lang=zh_cn&edition=full","pubTime":"2026-03-16 02:35","pubTimestamp":1773599713,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，华兰生物报收于15.26元，上涨0.07%，换手率0.48%，成交量7.61万手，成交额1.16亿元。股本股东变化股东户数变动近日华兰生物披露，截至2026年3月10日公司股东户数为14.9万户，较2月13日减少2000.0户，减幅为1.32%。户均持股数量由上期的1.21万股增加至1.23万股，户均持股市值为18.84万元。董秘最新回复投资者： 请问截止2026年3月10日，公司股东人数多少？董秘： 截至2026年3月10日，公司共有14.9万多名投资者，感谢您对公司的关注！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600000978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0188","BK0239","BK0046","002007","BK0185","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619160750","title":"华兰生物(002007)3月10日股东户数14.9万户，较上期减少1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619160750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619160750?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:15","pubTimestamp":1773393332,"startTime":"0","endTime":"0","summary":"证券之星消息，近日华兰生物披露，截至2026年3月10日公司股东户数为14.9万户，较2月13日减少2000.0户，减幅为1.32%。在生物制品行业个股中，华兰生物股东户数高于行业平均水平，截至3月10日，生物制品行业平均股东户数为3.45万户。从股价来看，2026年2月13日至2026年3月10日，华兰生物区间涨幅为0.33%，在此期间股东户数减少2000.0户，减幅为1.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300029193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","002007","BK0239","BK0185","BK0188","BK0028","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618727693","title":"股市必读：华兰生物（002007）3月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2618727693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618727693?lang=zh_cn&edition=full","pubTime":"2026-03-09 01:19","pubTimestamp":1772990350,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，华兰生物报收于15.28元，上涨1.66%，换手率0.64%，成交量10.0万手，成交额1.52亿元。董秘最新回复投资者： 请问公司增值税征收方式是否从 3% 简易征收调整为 13% 一般征收？本次调整为行业统一政策，预计将对行业产生一定影响。有什么实质手段提质增效董秘： 股价受经营环境、经营业绩及行业发展前景等多重因素综合影响。当日关注点来自交易信息汇总：3月6日主力资金净流入1005.46万元，呈现主力积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900000579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0188","002007","BK0185","BK0197","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617683282","title":"华兰生物：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2617683282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617683282?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:36","pubTimestamp":1772786170,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：公司股价长期低迷向下，估值是否合理？是否与公司治理不良有关？有什么实质手段提质增效华兰生物回复：股价受经营环境、经营业绩及行业发展前景等多重因素综合影响。公司始终坚持稳健经营，持续提升核心竞争力，以扎实的业绩支撑公司长期价值。未来，公司将进一步提高信息披露质量，保持稳定分红，积极传递公司内在价值，切实维护投资者利益。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600026332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0077","002007","BK0239","BK0197","BK0046","BK0185","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617285683","title":"华兰生物：血液制品中的罕见病药物仍适用3%简易征收","url":"https://stock-news.laohu8.com/highlight/detail?id=2617285683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617285683?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785834,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物03月06日在投资者关系平台上答复投资者关心的问题。本次税率调整预计增加的税收成本是多少？根据国家增值税相关政策，血液制品中的罕见病药物仍适用3%简易征收，其他血液制品业务不再适用3%简易征收。本次调整为行业统一政策，预计将对行业产生一定影响。对此，公司将密切关注政策变化，积极优化供应链与进项税管理，提升合规运营水平，努力降低政策影响，持续为公司和股东创造价值。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600026052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0185","BK0188","BK0046","BK0197","BK0028","002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614481700","title":"华兰生物(002007.SZ)：帕博利珠单抗注射液获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2614481700","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614481700?lang=zh_cn&edition=full","pubTime":"2026-02-25 18:09","pubTimestamp":1772014146,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰生物 公告，公司参股公司华兰安康生物股份有限公司收到国家药品监督管理局《药物临床试验批准通知书》，帕博利珠单抗注射液获同意按生物类似药开展临床试验。公告显示，帕博利珠单抗是一种靶向程序性死亡受体-1的人源化单克隆抗体。帕博利珠单抗通过阻断PD-1与其配体PD-L1/PD-L2的结合，恢复T细胞的肿瘤杀伤功能，增强人体免疫系统对抗肿瘤的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1407186.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002007","BK0028","BK0188","BK0185","BK0046","BK0197","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613382791","title":"华兰生物：截至2026年2月13日，公司共有15.1万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2613382791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613382791?lang=zh_cn&edition=full","pubTime":"2026-02-24 17:27","pubTimestamp":1771925226,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)02月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问最新一期公司的股东人数是多少？华兰生物回复：截至2026年2月13日，公司共有15.1万多名投资者。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400032713.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0185","BK0077","BK0239","BK0028","002007","BK0188","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610998720","title":"华兰生物：截至2026年2月10日，公司共有15.1万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2610998720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610998720?lang=zh_cn&edition=full","pubTime":"2026-02-11 17:09","pubTimestamp":1770800950,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)02月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年2月10日，公司股东人数多少？华兰生物回复：截至2026年2月10日，公司共有15.1万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100026809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002007","BK0188","BK0028","BK0197","BK0239","BK0185","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608635861","title":"华兰生物：截至2026年1月30日，公司共有15.3万多名投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2608635861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608635861?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:13","pubTimestamp":1770189208,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年1月31日，公司股东人数多少？华兰生物回复：截至2026年1月30日，公司共有15.3万多名投资者，感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400020036.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002007","BK0239","BK0077","BK0046","BK0185","BK0197","BK0188","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608435893","title":"华兰生物：2025年已实现流感疫苗出口至巴基斯坦、多米尼加等国家","url":"https://stock-news.laohu8.com/highlight/detail?id=2608435893","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608435893?lang=zh_cn&edition=full","pubTime":"2026-02-04 15:13","pubTimestamp":1770189206,"startTime":"0","endTime":"0","summary":"证券之星消息，华兰生物(002007)02月04日在投资者关系平台上答复投资者关心的问题。投资者提问：据报：美、欧、日韩等地流感爆发，公司流感用药出口情况或WHO申请情况？华兰生物回复：尊敬的投资者您好！公司持续推进流感疫苗国际化布局，2025年已实现流感疫苗出口至巴基斯坦、多米尼加等国家。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400020034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0188","BK0239","BK0046","002007","BK0185","BK0028","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608877829","title":"华兰生物（002007）披露收到药物临床试验批准通知书，2月3日股价上涨1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608877829","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608877829?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:18","pubTimestamp":1770128301,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，华兰生物报收于15.45元，较前一交易日上涨1.05%，最新总市值为282.34亿元。该股当日开盘15.37元，最高15.48元，最低15.3元，成交额达1.87亿元，换手率为0.77%。近日，华兰生物工程股份有限公司收到国家药品监督管理局下发的《药物临床试验批准通知书》，同意公司自主研发的重组Exendin-4-Fc融合蛋白注射液在成人肥胖或超重患者中开展临床试验。HL08为新一代GLP-1受体激动剂，具有延长生物半衰期、提升用药便利性与疗效持续性的特点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043119.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0185","BK0239","BK0077","BK0188","BK0197","BK0046","BK0028","002007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608826653","title":"华兰生物(002007.SZ)：重组Exendin-4-Fc融合蛋白注射液获准开展临试","url":"https://stock-news.laohu8.com/highlight/detail?id=2608826653","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608826653?lang=zh_cn&edition=full","pubTime":"2026-02-03 16:51","pubTimestamp":1770108703,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华兰生物(002007.SZ)公告，公司收到国家药品监督管理局下发的《药物临床试验批准通知书》，药物名称为：重组Exendin-4-Fc融合蛋白注射液(简称“HL08”)，该药物原获批开展临床试验的适应症为拟用于改善2型糖尿病患者的血糖控制;本次获批新增适应症为拟用于改善肥胖患者的体重控制。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401038.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"华兰生物(002007.SZ)：重组Exendin-4-Fc融合蛋白注射液获准开展临试","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","002007","BK0185","BK0239","BK0028","BK0197","BK0046","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606263739","title":"股市必读：华兰生物（002007）1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606263739","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606263739?lang=zh_cn&edition=full","pubTime":"2026-01-26 02:27","pubTimestamp":1769365628,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，华兰生物报收于15.61元，上涨1.36%，换手率1.1%，成交量17.3万手，成交额2.69亿元。董秘最新回复投资者： 公司能否年报和中报都10派5，来回馈持有多年的股东们董秘： 您好！公司始终重视股东回报，上市以来已累计分红62.53亿元。当日关注点来自交易信息汇总：1月23日主力资金净流入743.65万元，显示主力对华兰生物短期走势持积极态度。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0197","BK0028","BK0188","BK0185","002007","BK0239","BK0046","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605041961","title":"股市必读：华兰生物（002007）1月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605041961","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605041961?lang=zh_cn&edition=full","pubTime":"2026-01-23 02:08","pubTimestamp":1769105295,"startTime":"0","endTime":"0","summary":"截至2026年1月22日收盘，华兰生物报收于15.4元，上涨0.59%，换手率0.53%，成交量8.39万手，成交额1.29亿元。董秘： 截至2026年1月20日，公司共有14.8万多名投资者，感谢您对公司的关注！来自公司公告汇总：控股子公司重组带状疱疹疫苗获准开展临床试验，属预防用生物制品1.3类新药。该疫苗为预防用生物制品1.3类新药，适用于预防带状疱疹，不适用于预防原发性水痘。目前国内已有两款带状疱疹疫苗上市，市场需求随老龄化加剧持续增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300001091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0188","BK0197","BK0185","BK0077","BK0239","002007","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775172447442,"stockEarnings":[{"period":"1week","weight":0.0363},{"period":"1month","weight":-0.0211},{"period":"3month","weight":-0.0178},{"period":"6month","weight":-0.0378},{"period":"1year","weight":-0.0311},{"period":"ytd","weight":-0.0178}],"compareEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":-0.0493},{"period":"3month","weight":-0.0125},{"period":"6month","weight":0.0094},{"period":"1year","weight":0.1699},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"华兰生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"148000人(较上一季度减少0.67%)","perCapita":"10629股","listingDate":"2004-06-25","address":"河南省新乡市红旗区华兰大道甲1号","registeredCapital":"182745万元","survey":" 华兰生物工程股份有限公司的主营业务是血液制品、疫苗、基因工程产品的研发、生产和销售。公司的主要产品是人血白蛋白、静注丙球、其他血液制品、流感疫苗。","listedPrice":15.74},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华兰生物,002007,华兰生物股票,华兰生物股票老虎,华兰生物股票老虎国际,华兰生物行情,华兰生物股票行情,华兰生物股价,华兰生物股市,华兰生物股票价格,华兰生物股票交易,华兰生物股票购买,华兰生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华兰生物(002007)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华兰生物(002007)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}